Edgewise Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +434.4% | +117.5% | +28.7% | -7.4% | +43.2% | +13.5% | |
| – | +439.2% | +118.9% | +25.8% | -8.4% | +45.4% | +14.3% | |
| – | +343.6% | -85.2% | +41.3% | +291.5% | -51.6% | +46.8% | |
| – | +445.8% | +117.5% | +25.3% | -9.5% | +47.7% | +12.7% | |
| – | – | – | -54.2% | – | – | – | |
| – | +3.6% | +76.7% | +835.6% | – | – | – | |
| – | +297.5% | -93.4% | +87.9% | +4.0% | +30.2% | +9.9% | |
| – | +283.6% | +142.3% | +57.6% | +1.1% | +42.3% | +14.7% | |
| – | – | – | – | +61.2% | +1.6% | +1.8% | |
| – | +136.9% | +143.2% | +58.9% | -34.1% | +38.6% | +7.7% | |
| – | – | – | +26.4% | -8.0% | +44.0% | +13.7% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | +0.6% | +8.3% | +18.9% | +45.0% | +11.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.